Aerogen - About the company
Aerogen is an acquired company based in Galway (Ireland), founded in 1997 by . It operates as a Manufacturer of vibrating mesh nebulizers for aerosol drug delivery. Aerogen has raised $18M in funding. The company has 9 active competitors, including 4 funded and 2 that have exited. Its top competitors include companies like Qnovia, Nebu~Flow and Omega Life Science.
Company Details
Manufacturer of vibrating mesh nebulizers for aerosol drug delivery. These devices facilitate respiratory therapy across various ventilation settings, including invasive and non-invasive mechanical ventilation, high-flow, and self-ventilating therapies. The technology is designed for ease of use and effectiveness. Products include single-patient-use devices and handheld units for use in conjunction with other respiratory equipment. The company also provides controllers and accessories.
- Website
- Social
- Email ID
- @aerogen.com
- Registered Address
- na
Legal entities associated with Aerogen
Aerogen is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CIN: 0769.712.618 Belgium, Active | Jul 01, 2021 | - | - | - |
CIN: T19UF9988G Singapore, Deadpooled | Dec 05, 2019 | - | - | - |
Dec 16, 2019 | $927K (as on Mar 31, 2022) | - |
Get your free copy of Aerogen's company profile
Aerogen's acquisition details
Aerogen got acquired by Nektar on Aug 15, 2005 at an acquisition amount of $32M. It was facilitated by Aquilo Partners.
Click to take a look at Aerogen's acquisition in detail
Aerogen's funding and investors
Aerogen has raised a total funding of $18M over 4 rounds. Its first funding round was on Sep 17, 1998. Its latest funding round was a Grant (prize money) round on Jun 01, 2022 for $94.8K. 1 investor participated in its latest round, which include InterWest Partners, J P Morgan, Invesco Mutual Fund and Healthcap.
Aerogen has 12 institutional investors including InterWest Partners, J P Morgan and Invesco Mutual Fund.
Here is the list of recent funding rounds of Aerogen:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Jun 01, 2022 | $94.8K | Grant (prize money) | 6386680 | 6014923 | |
Jan 01, 2020 | $236K | Grant (prize money) | 5805017 | 1096348 | |
Jan 02, 2019 | $11.5M | Post IPO | 9146944 | 2342554 |
Access funding benchmarks and valuations. Sign up today!View details of Aerogen's funding rounds and investors
Aerogen's founders and board of directors
The founders of Aerogen is . is the CEO of Aerogen.
Here are the details of Aerogen's key team members:
- : Founder & CEO of Aerogen. They serve on the board of .Contact Info:
View details of
Access 秘密研究所 on any website
Our Google Chrome extension lets you view company details while browsing their websites
Aerogen's Competitors and alternates
Top competitors of Aerogen include Qnovia, Nebu~Flow and Omega Life Science. Here is the list of Top 10 competitors of Aerogen, ranked by 秘密研究所 score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | 秘密研究所 Score |
|---|---|---|---|---|---|
1st | 1997, Galway (Ireland), Acquired | Manufacturer of vibrating mesh nebulizers for aerosol drug delivery | $18M | InterWest Partners, J P Morgan听&补尘辫;听 | 58/100 |
2nd |  Qnovia 2018, Richmond (United States), Series B | Developer of inhaled drug delivery devices to deliver a broad range of pharmaceuticals | $50M | DG Ventures, Evolution VC Partners听&补尘辫;听 | 50/100 |
3rd |  Nebu~Flow 2019, Glasgow (United Kingdom), Series A | Developer of aerosol delivery platform technology | $7.97M | , Ascension听&补尘辫;听 | 28/100 |
4th | _1569584739981.png?height=40&width=40){kind=logo} Omega Life Science 2011, Migdal HaEmek (Israel), Funding Raised | Developer of a nebulizer | - | 22/100 | |
5th | Manufacturer of medical device for nebulized therapies | - | 21/100 | ||
6th | Developer of inhalation device to treat people suffering from respiratory diseases. | - | - | 19/100 | |
7th |  LIITA Care 2012, Copenhagen (Denmark), Unfunded | Developer of novel therapies to treat respiratory diseases | - | - | 16/100 |
8th |  Afrezza 2009, United States, Unfunded | Developer of an inhaled insulin for type 1 and 2 diabetes | - | - | 14/100 |
9th |  Portable Inhale Nebulizer 2020, United States, Deadpooled | Provider of an online store for the purchase of nebulizers | - | - | 9/100 |
10th | 2013, Fairfield (United States), Series A | Developer of medical devices for respiratory diseases | $300K | - |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Aerogen's competitors? Click to see the top ones
Aerogen's Investments and acquisitions
Aerogen has made no investments or acquisitions yet.
Reports related to Aerogen
Here is the latest report on Aerogen's sector:
View
News related to Aerogen
Media has covered Aerogen for a total of 5 events in the last 1 year, 3 of them have been about company updates and 1 about partnerships.
鈥�
Media Bulletins鈥�Mar 19, 2025鈥�Aerogen
鈥�
IndiaMedToday鈥�Mar 19, 2025鈥�Aerogen
鈥�
Drug Delivery Business鈥�Jan 15, 2025鈥�Aerogen
鈥�
The Irish Times鈥�Jan 15, 2025鈥�Aerogen
鈥�
BioSpectrum India鈥�Oct 11, 2024鈥�Aerogen,
鈥�
鈥�
鈥�
Silicon Republic鈥�Dec 03, 2020鈥�Aerogen
鈥�
The Irish Times鈥�Oct 26, 2020鈥�Aerogen
鈥�
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQ's about Aerogen
Explore our recently published companies
- Tenevia - Meylan based, 2012 founded, Unfunded company
- Chat Diagram - Singapore based, 2024 founded, Unfunded company
- BuildQ - Sacramento based, 2024 founded, Unfunded company
